Barinthus Biotherapeutics Plc ADR (BRNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 155,935 | 43,266 | 0 | 0 | 0 |
| Receivables | 4,003 | 3,226 | 0 | 0 | 0 |
| TOTAL | $163,365 | $47,901 | $0 | $0 | $0 |
| Non-Current Assets | |||||
| PPE Net | 1,003 | 629 | N/A | N/A | N/A |
| Other Non-Current Assets | 2,123 | 2,136 | 0 | 0 | 0 |
| TOTAL | $3,126 | $2,765 | $N/A | $N/A | $N/A |
| Total Assets | $166,491 | $50,666 | $0 | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,833 | 4,667 | 0 | 0 | 0 |
| Accrued Expenses | 3,273 | 2,537 | 0 | 0 | 0 |
| TOTAL | $8,650 | $7,641 | $0 | $0 | $0 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 346 | 245 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 210,554 | 80,007 | -42 | 69 | 130 |
| TOTAL | $210,672 | $79,937 | $N/A | $N/A | $N/A |
| Total Liabilities | $219,322 | $87,578 | $0 | $0 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 34,328 | N/A | N/A | N/A | N/A |
| Common Shares | 86 | N/A | 0 | 0 | 0 |
| Retained earnings | -72,988 | -57,720 | 0 | 0 | 0 |
| Other shareholders' equity | -2,386 | -852 | 0 | 0 | 0 |
| TOTAL | $-52,831 | $-36,912 | $0 | $0 | $0 |
| Total Liabilities And Equity | $166,491 | $50,666 | $0 | $0 | $0 |